XML 15 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Revenue:        
Product revenue $ 284,887 $ 251,210 $ 533,952 $ 483,313
Service revenue 181,682 162,133 350,167 312,507
Total revenue 466,569 413,343 884,119 795,820
Cost of Revenue:        
Cost of product revenue 108,910 91,203 206,541 174,573
Cost of service revenue 97,116 89,383 189,498 172,946
Total cost of revenue 206,026 180,586 396,039 347,519
Gross profit 260,543 232,757 488,080 448,301
Expenses:        
Sales and marketing 76,652 75,217 156,481 150,353
General and administrative 54,317 44,920 103,612 87,519
Research and development 25,412 24,317 50,032 49,323
Income from operations 104,162 88,303 177,955 161,106
Interest expense (8,204) (7,259) (16,508) (13,563)
Interest income 928 559 1,748 984
Income before provision for income taxes 96,886 81,603 163,195 148,527
Provision for income taxes 29,680 24,665 49,964 45,011
Net income 67,206 56,938 113,231 103,516
Less: Net income attributable to noncontrolling interest 4 26 10 10
Net income attributable to IDEXX Laboratories, Inc. stockholders $ 67,202 $ 56,912 $ 113,221 $ 103,506
Earnings per Share:        
Basic $ 0.75 $ 0.61 $ 1.26 $ 1.10
Diluted $ 0.74 $ 0.60 $ 1.25 $ 1.09
Weighted Average Shares Outstanding:        
Basic 89,824 93,384 89,874 93,829
Diluted 90,817 94,306 90,858 94,934